skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

4757

OncoTargets and Therapy

(165,523) Views

Editor in Chief Professor Hans-Joachim Schmoll

1178-6930

Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine
Steven E McCormack, Erica D Warlick

Temozolomide in malignant glioma
Gregor Dresemann

Current and emerging therapies for the treatment of pancreatic cancer
Rebecca A Moss, Clifton Lee

Dynamic changes to survivin subcellular localization are initiated by DNA damage
Maritess Gay Asumen, Tochukwu V Ifeacho, Luke Cockerham, et al

The dual kinase complex FAK-Src as a promising therapeutic target in cancer
Victoria Bolós, Joan Manuel Gasent, Sara López-Tarruella, et al

A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency
Mariam Hammadi, Jacques-Olivier Pers, Christian Berthou, et al

Anti-angiogenesis therapies: their potential in cancer management
Andrew Eichholz, Shairoz Merchant, Andrew M Gaya

First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab
Carmen Diana Schweighofer, Clemens-Martin Wendtner

Update on options for treatment of metastatic castration-resistant prostate cancer
Prakash Vishnu, Winston W Tan

New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab
Argirios Moustakas, Teri N Kreisl

CTLA-4 blockade: therapeutic potential in cancer treatments
Ahmad A Tarhini, Fatima Iqbal

An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes
Jacqueline S Garcia, Nitin Jain, Lucy A Godley

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio